Revvity Inc at JPMorgan Healthcare Conference Transcript
Perfect. Hi. Good afternoon, everyone. This is Rachel Vatnsdal from the life science tools and diagnostics team here at JPMorgan. I am joined on stage by Revvity and Prahlad, the CEO. So as is typical, this is going to be a 40-minute session. It will be roughly 20 minutes of a presentation followed by 20 minutes of Q&A. For any of you in the audience have questions, feel free to ping me.
With that, I will pass it off to Prahlad.
Good morning, everyone, and thank you, Rachel, for inviting us again to share our exciting story. And I also want to sort of commend you and your colleagues for being able to pull this off flawlessly year-over-year.
Before I begin, I wanted to invite your attention to our safe harbor statement and encourage you to visit the Investors section on our website, revvity.com for any forward-looking statements and additional disclosures that are made here today.
For
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |